24.42
price up icon15.63%   3.30
pre-market  Pre-mercato:  24.34   -0.08   -0.33%
loading

Summit Therapeutics Inc Borsa (SMMT) Ultime notizie

pulisher
Apr 16, 2026

Summit Therapeutics Inc Stock (SMMT) Moved Up by 12.03% on Apr 16: Drivers Behind the Movement - TradingKey

Apr 16, 2026
pulisher
Apr 16, 2026

Wall Street Hits New Records, Oil Surges On Hormuz Toll Drama: What's Moving Markets Thursday? - Benzinga

Apr 16, 2026
pulisher
Apr 16, 2026

Summit Therapeutics (NASDAQ:SMMT) Stock Price Up 8.2%Still a Buy? - MarketBeat

Apr 16, 2026
pulisher
Apr 16, 2026

SMMT Stock Up 24% in Three Months: Here's What You Need to Know - Yahoo Finance

Apr 16, 2026
pulisher
Apr 16, 2026

Been holding for so long - Moomoo

Apr 16, 2026
pulisher
Apr 14, 2026

Summit Therapeutics Stock Slumps After Partner Akeso Gets FDA Nod For Cancer Drug: Retail’s Optimistic - MSN

Apr 14, 2026
pulisher
Apr 14, 2026

How Summit Therapeutics Inc. (SMMT) Affects Rotational Strategy Timing - Stock Traders Daily

Apr 14, 2026
pulisher
Apr 14, 2026

Summit Therapeutics has scarcity value in a crowded drug race: Analyst - MSN

Apr 14, 2026
pulisher
Apr 12, 2026

What makes Summit Therapeutics (SMMT) one of the best large caps under $30 - MSN

Apr 12, 2026
pulisher
Apr 12, 2026

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2025 - ADVFN

Apr 12, 2026
pulisher
Apr 10, 2026

Aug PostEarnings: Can Summit Therapeutics Inc be the next market leader2026 Investor Takeaways & Growth Focused Entry Point Reports - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 10, 2026

SMMT News | SUMMIT THERAPEUTICS INC (NASDAQ:SMMT) - ChartMill

Apr 10, 2026
pulisher
Apr 09, 2026

Inflation Data: Can Summit Therapeutics Inc stock outperform in a bear marketBreakout Watch & Stock Portfolio Risk Control - baoquankhu1.vn

Apr 09, 2026
pulisher
Apr 09, 2026

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026 - Meyka

Apr 09, 2026
pulisher
Apr 09, 2026

Stifel initiates coverage of Summit Therapeutics (SMMT) with buy recommendation - MSN

Apr 09, 2026
pulisher
Apr 09, 2026

This Inhibrx Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Sahm

Apr 09, 2026
pulisher
Apr 09, 2026

Summit Therapeutics Has Scarcity Value In A Crowded Drug Race: Analyst - Sahm

Apr 09, 2026
pulisher
Apr 09, 2026

SMMT Upgraded to Buy by Citigroup on April 08, 2026 - Meyka

Apr 09, 2026
pulisher
Apr 09, 2026

Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors - TipRanks

Apr 09, 2026
pulisher
Apr 08, 2026

SMMT : POTENTIAL BOUNCEBACK Click Through The Up Coming Page (2dUA4zfHbg) - Mshale

Apr 08, 2026
pulisher
Apr 08, 2026

SUMMIT THERAPEUTICS INC BIG TRADING SWING | SMMT STOCK Simply Click The Next Internet Page (JHLdCFn8fQ) - Mshale

Apr 08, 2026
pulisher
Apr 08, 2026

Citigroup starts coverage of Summit Therapeutics Inc (SMMT), Apr 08 2026, Buy - Meyka

Apr 08, 2026
pulisher
Apr 08, 2026

What's Going On With Summit Therapeutics Stock Wednesday?Summit Therapeutics (NASDAQ:SMMT) - Benzinga

Apr 08, 2026
pulisher
Apr 08, 2026

$Summit Therapeutics (SMMT.US)$ - Moomoo

Apr 08, 2026
pulisher
Apr 08, 2026

Stifel Initiates Coverage on Summit Therapeutics (SMMT) with 'Bu - GuruFocus

Apr 08, 2026
pulisher
Apr 08, 2026

Pullback Watch: Is Summit Therapeutics Inc forming higher highs and higher lowsQuarterly Portfolio Review & Low Drawdown Investment Ideas - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 08, 2026

Summit Therapeutics (NASDAQ:SMMT) Now Covered by Analysts at Stifel Nicolaus - MarketBeat

Apr 08, 2026
pulisher
Apr 08, 2026

Tudor Investment Corp ET AL Takes $7.17 Million Position in Summit Therapeutics PLC $SMMT - MarketBeat

Apr 08, 2026
pulisher
Apr 08, 2026

Stifel Initiates Coverage on Summit Therapeutics (SMMT) with 'Buy' Rating | SMMT Stock News - GuruFocus

Apr 08, 2026
pulisher
Apr 08, 2026

Stifel Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $45 - Moomoo

Apr 08, 2026
pulisher
Apr 08, 2026

Aug Selloffs: Is Summit Therapeutics Inc impacted by rising ratesQuarterly Market Review & High Accuracy Swing Trade Signals - baoquankhu1.vn

Apr 08, 2026
pulisher
Apr 07, 2026

Stifel Initiates Summit Therapeutics(SMMT.US) With Buy Rating, Announces Target Price $45 - Moomoo

Apr 07, 2026
pulisher
Apr 07, 2026

Sentiment Recap: Does Summit Therapeutics Inc have a sustainable dividendInsider Buying & Expert Curated Trade Ideas - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 07, 2026

Summit Therapeutics Inc. (SMMT) Highlights Ivonescimab Progress at WCLC 2025 - MSN

Apr 07, 2026
pulisher
Apr 07, 2026

Aberdeen Group plc Reduces Stake in Summit Therapeutics PLC $SMMT - MarketBeat

Apr 07, 2026
pulisher
Apr 06, 2026

Summit Therapeutics (SMMT) asks shareholders to approve 8M-share Plan increase - Stock Titan

Apr 06, 2026
pulisher
Apr 06, 2026

Summit Therapeutics (SMMT) Expands its Phase 3 Trials for Ivonescimab - MSN

Apr 06, 2026
pulisher
Apr 05, 2026

Chart Watch: Whats next for Summit Therapeutics Inc stockEarnings Beat & Long-Term Growth Plans - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 04, 2026

We're Not Very Worried About Summit Therapeutics' (NASDAQ:SMMT) Cash Burn Rate - Moomoo

Apr 04, 2026
pulisher
Apr 04, 2026

Does Summit Therapeutics (SMMT) Expanding Ivonescimab Trials Clarify Its Single-Asset Oncology Strategy? - simplywall.st

Apr 04, 2026
pulisher
Apr 03, 2026

Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now - AOL.com

Apr 03, 2026
pulisher
Apr 03, 2026

(SMMT) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Apr 03, 2026
pulisher
Apr 02, 2026

Wells Fargo Maintains Summit Therapeutics(SMMT.US) With Buy Rating, Maintains Target Price $30 - Moomoo

Apr 02, 2026
pulisher
Apr 02, 2026

Summit plunges 80 percent after muscle-wasting disorder drug fails - AOL.com

Apr 02, 2026
pulisher
Apr 02, 2026

SMMT Stock Price, Quote & Chart | SUMMIT THERAPEUTICS INC (NASDAQ:SMMT) - ChartMill

Apr 02, 2026
pulisher
Apr 01, 2026

Assenagon Asset Management S.A. Invests $1.04 Million in Summit Therapeutics PLC $SMMT - MarketBeat

Apr 01, 2026
pulisher
Mar 31, 2026

Summit Therapeutics PLC (NASDAQ:SMMT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Barclays Maintains Summit Therapeutics (SMMT) Underweight Recommendation - MSN

Mar 31, 2026
pulisher
Mar 31, 2026

Barclays Remains a Hold on Summit Therapeutics (SMMT) - The Globe and Mail

Mar 31, 2026
$48.48
price down icon 0.45%
$54.68
price up icon 0.77%
$102.12
price up icon 2.66%
$149.27
price down icon 2.14%
$142.79
price down icon 2.69%
ONC ONC
$320.70
price up icon 0.24%
Capitalizzazione:     |  Volume (24 ore):